by McKesson Ventures | Apr 9, 2024 | Press Releases
On April 9, 2024, CancerIQ’s Founder and CEO Feyi Ayodele was named as one of Modern Healthcare’s Top Innovators of 2024. The list acknowledges innovators that are improving quality and access to care, as well as constantly striving to improve the clinical and...
by McKesson Ventures | Apr 8, 2024 | Press Releases
On Monday, April 8, 2024, Florida-based biotechnology research company Aster Insights announced that it has partnered with the Food & Drug Administration (FDA) to examine the relationship between the scoring algorithms used in diagnostic testing and key patient...
by McKesson Ventures | Jan 22, 2024 | Press Releases
On Monday, January 22nd, life science solutions company Saama announced a variety of new additions to its AI-based platform. The new features include the release of generative AI chat, interactive review listings, and an increased prioritization of cross-functional...
by McKesson Ventures | Dec 14, 2023 | Press Releases
On Thursday, December 14th, pharmaceutical marketing and trade magazine PM360 announced its list of innovators in the pharmaceutical, biotechnology, medical device, and biotechnology industries. These innovators were named for their achievements across a variety of...
by McKesson Ventures | Dec 8, 2023 | Press Releases
Aster Insights has announced three upcoming presentations at the 2023 American Society of Hematology (ASH) Annual Meeting, which will be held from December 9-12 in San Diego, CA. Three ORIEN scientists from Moffitt Cancer Center will present key findings on multiple...
by McKesson Ventures | Dec 7, 2023 | Press Releases
On Thursday, December 7, 2023, oncology and cancer-health screening company Cancer IQ announced a partnership with the Boston University School of Public Health to study racial and ethnic disparities in genetic counseling and testing for at-risk cancer patients. This...
